文献速递白血病淋巴瘤

单细胞DNA扩增子测序揭示T细胞急性淋巴细胞白血病的克隆异质性与演化

Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.
PubMed 文献 · Blood · 2021-01-01

该研究采用Tapestri平台对8例T-ALL患者的25份样本共108188个细胞进行单细胞靶向DNA测序,覆盖110个基因的305个扩增子。多数病例诊断时存在一个主要克隆(>35%细胞)及若干次要克隆(部分<1%),4例患者携带>2个NOTCH1突变。纵向分析可检出残留白血病细胞及诊断时次要、后期演变为临床相关主要克隆的克隆,表明该法可灵敏检测T-ALL克隆结构与演化。

要点

  • 单细胞DNA扩增子测序可灵敏解析T-ALL诊断时克隆结构。
  • 诊断时常见一个主要克隆(>35%细胞)伴多个次要克隆(部分<1%)。
  • 4例患者携带>2个NOTCH1突变,部分位于次要克隆。

核心结论

  • 单细胞DNA扩增子测序是检测T-ALL克隆结构与演化的灵敏方法。

研究设计与样本

  • 采用Tapestri平台单细胞靶向DNA测序,定制ALL panel覆盖110个基因的305个扩增子,每样本每时间点约4400个细胞。
  • 共分析8例T-ALL患者的25份样本、108188个细胞。

主要发现

  • 诊断时通常观察到一个主要克隆(>35%细胞)及若干次要克隆,部分次要克隆<1%总细胞数。
  • 4例患者有>2个NOTCH1突变,部分存在于次要克隆中。
  • 纵向样本分析检出残留白血病细胞及诊断时次要、后期演变为临床相关主要克隆的克隆。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive leukemia that is most frequent in children and is characterized by the presence of few chromosomal rearrangements and 10 to 20 somatic mutations in protein-coding regions at diagnosis. The majority of T-ALL cases harbor activating mutations in NOTCH1 together with mutations in genes implicated in kinase signaling, transcriptional regulation, or protein translation. To obtain more insight in the level of clonal heterogeneity at diagnosis and during treatment, we used single-cell targeted DNA sequencing with the Tapestri platform. We designed a custom ALL panel and obtained accurate single-nucleotide variant and small insertion-deletion mutation calling for 305 amplicons covering 110 genes in about 4400 cells per sample and time point. A total of 108 188 cells were analyzed for 25 samples of 8 T-ALL patients. We typically observed a major clone at diagnosis (>35% of the cells) accompanied by several minor clones of which some were less than 1% of the total number of cells. Four patients had >2 NOTCH1 mutations, some of which present in minor clones, indicating a strong pressure to acquire NOTCH1 mutations in developing T-ALL cells. By analyzing longitudinal samples, we detected the presence and clonal nature of residual leukemic cells and clones with a minor presence at diagnosis that evolved to clinically relevant major clones at later disease stages. Therefore, single-cell DNA amplicon sequencing is a sensitive assay to detect clonal architecture and evolution in T-ALL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Albertí-Servera L, Demeyer S, Govaerts I, et al. Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia. Blood. 2021. PMID: 32812017. doi:10.1182/blood.2020006996

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。